Improving HIV counseling through an educational app about undetectable viral loads.
Integrating U=U into HIV counseling: a cluster-randomized efficacy trial (INTUIT 2.0)
This study is testing a helpful app called 'Undetectable & You' that teaches people living with HIV about the idea that if their viral load is undetectable, they can't pass on the virus, and it aims to see if using the app can help them stick to their treatment and stay healthy in South Africa.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10925871 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV counseling by integrating the concept of 'Undetectable = Untransmittable' (U=U) into patient education. It involves refining an educational app called 'Undetectable & You,' which was co-created with people living with HIV and healthcare providers. The app shares personal stories and scientific information to help patients understand that if their viral load is undetectable, they cannot transmit HIV. The study will evaluate the app's effectiveness in improving adherence to antiretroviral therapy (ART) and achieving viral suppression among participants in South Africa.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in South Africa who are seeking to understand their treatment options and improve their health.
Not a fit: Patients who are not living with HIV or those who are not engaged in HIV care may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients with HIV by reducing stigma and improving their health outcomes through better adherence to treatment.
How similar studies have performed: Previous research has shown that educational interventions like U=U can significantly improve knowledge and health outcomes among people living with HIV, indicating a promising approach.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Bor, Jacob — Boston University Medical Campus
- Study coordinator: Bor, Jacob
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.